2001
Meridica strengthens marketing team through addition of Business Development Manager
-
09 August 2001
Meridica Ltd, the new drug-delivery technology company formed by PA Consulting Group, today announced the appointment of Alf Hannan as Business Development Manager.
A major part of Meridica's strategy is to seek and build partnerships with pharmaceutical companies in order to develop its innovative devices in conjunction with suitable drugs. Alf Hannan will be responsible, on a global basis, for attracting partners and managing this key activity.
Commenting on his appointment Alf Hannan said:
"Meridica is helping to meet the high world-wide demand for new drug-delivery technologies. This is an exciting time to join a company developing innovative, quality devices, which will allow new drug formulations to reach the market in record time. It's an opportunity for me to add my skills and experience to the leading team in this pharmaceutical sector."
Ian Smith, CEO of Meridica, comments:
"Alf Hannan's appointment will allow us to communicate the benefits of our technology, collaborations and licensing activities more effectively to pharmacuetical companies - large and small - who need every business advantage in a increasingly competitive and regulated industry."
David Edwards, Director of Strategic Marketing at Meridica, adds:
"Alf Hannan's extensive industry experience and contacts will strengthen and bring focus to our marketing activities".
Alf Hannan joins the Meridica team after nine years with Betts UK Limited, a leader in the manufacture of metered-dose inhaler actuators and drug-delivery devices, as well as in laminate tubes for dentifrice products. As Business Development Manager at Betts, he led the team which introduced a pipeline of development projects to the pharmaceutical segment of the business. Prior to joining Betts, Alf spent several years in various product management and marketing roles with Bespak, a manufacturer of drug-delivery devices and a leader in aerosol valves for metered-dose inhalers.
Meridica has a number of new technologies and products under development, some at an advanced stage:
Xcelovent™ - a novel device that provides breath-actuated delivery of drugs from pressurised metered-dose inhalers
Xcelodose™- innovative, automated and programmable equipment for the precise metering of drug powder into capsules and other solid dosage form containers
Xcelovair™ - a dry powder inhaler designed to accommodate a wide range of drugs and formulations for pulmonary delivery and to meet the exacting standards of global regulatory authorities
Xcelonase™ - a nasal drug delivery device designed to exceed the market standards in nasal drug-delivery, suitable for a wide range of formulations, for nasal delivery in both adults and children.
ends
For more information, please contact:
|
| David Edwards |
| PA Conuslting Group |
| Cambridge Technology Centre Melbourn |
| Royston |
| SG8 6DP |
|
|
Tel: +44 1763 261 222 |
|
E-mail:
david.edwards@meridica.com |
|
|
|
Notes to editors
1. Meridica's vision is to become the leading source of creative drug delivery systems and drug products for the pharmaceutical sector, based on the excellence and quality of its products. It will enable the full exploitation of the 'biotechnological' advances made in the last decade, and build a position as the leading industry provider of cutting-edge solutions to delivery systems.
Although Meridica Limited is a wholly-owned PAGroup company, it operates as a separate and independent entity with its own board, senior management team, finances and development organisation.
2. PA Consulting Group is a leading management, systems and technology consulting firm, with a unique combination of these capabilities. Established almost 60 years ago, and operating world-wide from over 40 offices in more than 20 countries, PA draws on the knowledge and experience of around 4,000 people, whose skills span the initial generation of ideas and insights all the way through to detailed implementation.
PA builds strategies for the creation and capture of shareholder and customer value, and helps clients accelerate business growth through innovation and the application of technology. PA works with clients to improve performance, mobilise human resources and deliver change effectively, including managing major projects, and designing and implementing enterprise-wide systems and full e-business solutions.
PA focuses on creating benefits for clients rather than merely proposing them, and this focus is supported by an outstanding implementation track record in every major industry and for governments around the world. PA also develops leading-edge technology both for its clients and within its own portfolio of venture companies in areas ranging from software to wireless technology to life sciences.
PA distinguishes itself from its competitors through the range and quality of its people, the depth of its industry insight, its development and use of technology, and also its independence and culture of respect, collaboration and flexibility in working with clients.
We are proud that our clients say "PA makes it happen".
|
